TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+8.84%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.19B
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| 1 |
Merck
MRK
|
+$253M |
| 2 |
Energy Select Sector SPDR Fund
XLE
|
+$164M |
| 3 |
Eli Lilly
LLY
|
+$159M |
| 4 |
NVIDIA
NVDA
|
+$147M |
| 5 |
Franco-Nevada
FNV
|
+$120M |
Top Sells
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Amazon
AMZN
|
+$240M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$237M |
| 4 |
Pfizer
PFE
|
+$214M |
| 5 |
Johnson & Johnson
JNJ
|
+$211M |
Sector Composition
| 1 | Technology | 19.77% |
| 2 | Financials | 19.42% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Acadia Pharmaceuticals
ACAD
$4.28B
| $2.2M | ﹤0.01% |
116,921
+13,600
| +13% | +$256K |
|
|
HAYN
952
DELISTED
Haynes International, Inc.
HAYN
| $2.19M | ﹤0.01% |
43,660
| – | – |
|
953
Clarivate
CLVT
$3.01B
| $2.18M | ﹤0.01% |
231,992
+4,467
| +2% | +$41.9K |
|
954
Origin Bancorp
OBK
$1.22B
| $2.17M | ﹤0.01% |
67,560
+7,800
| +13% | +$251K |
|
955
Lantheus
LNTH
$3.65B
| $2.17M | ﹤0.01% |
26,290
+14,600
| +125% | +$1.21M |
|
956
US Physical Therapy
USPH
$1.29B
| $2.17M | ﹤0.01% |
22,132
-482
| -2% | -$47.2K |
|
957
Pinnacle Financial Partners
PNFP
$7.63B
| $2.16M | ﹤0.01% |
39,182
-290
| -0.7% | -$16K |
|
958
Utz Brands
UTZ
$1.13B
| $2.16M | ﹤0.01% |
131,110
+9,000
| +7% | +$148K |
|
959
Allegiant Air
ALGT
$1.15B
| $2.15M | ﹤0.01% |
23,418
| – | – |
|
960
Liberty Energy
LBRT
$1.62B
| $2.15M | ﹤0.01% |
167,588
-18,000
| -10% | -$231K |
|
961
DaVita
DVA
$9.77B
| $2.14M | ﹤0.01% |
26,445
+12,918
| +95% | +$1.05M |
|
962
Surgery Partners
SGRY
$2.83B
| $2.14M | ﹤0.01% |
61,991
+32,000
| +107% | +$1.1M |
|
963
Universal Health Services
UHS
$11.8B
| $2.13M | ﹤0.01% |
16,737
-2,648
| -14% | -$337K |
|
964
Franklin Resources
BEN
$12.9B
| $2.12M | ﹤0.01% |
78,601
+1,992
| +3% | +$53.7K |
|
965
MYR Group
MYRG
$2.77B
| $2.12M | ﹤0.01% |
16,800
| – | – |
|
966
Comerica
CMA
$8.88B
| $2.12M | ﹤0.01% |
48,729
-16,833
| -26% | -$731K |
|
967
Matsons
MATX
$3.33B
| $2.11M | ﹤0.01% |
35,300
-5,700
| -14% | -$340K |
|
968
Alamo Group
ALG
$2.56B
| $2.1M | ﹤0.01% |
11,400
-1,900
| -14% | -$350K |
|
|
KREF
969
KKR Real Estate Finance Trust
KREF
$646M
| $2.1M | ﹤0.01% |
184,100
-82,500
| -31% | -$940K |
|
970
First Hawaiian
FHB
$3.21B
| $2.07M | ﹤0.01% |
100,391
-15,451
| -13% | -$319K |
|
|
JUGG
971
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $2.05M | ﹤0.01% |
200,000
| – | – |
|
|
BLU
972
DELISTED
BELLUS Health Inc.
BLU
| $2.04M | ﹤0.01% |
283,827
+22,590
| +9% | +$162K |
|
973
Denali Therapeutics
DNLI
$2.25B
| $2.03M | ﹤0.01% |
88,322
-10,887
| -11% | -$251K |
|
|
SAGE
974
DELISTED
Sage Therapeutics
SAGE
| $2.03M | ﹤0.01% |
48,455
| – | – |
|
975
Steven Madden
SHOO
$2.22B
| $2.03M | ﹤0.01% |
56,400
+3,400
| +6% | +$122K |
|